{"slideshow_credits": null, "snippet": "Allergan, the maker of Botox, sought a $10 billion deal for Salix that would not have required shareholder approval, a move intended to derail a takeover effort by Valeant and Pershing Square.", "abstract": "Allergan, the maker of Botox, sought a $10 billion deal for Salix that would not have required shareholder approval, a move intended to derail a takeover effort by Valeant and Pershing Square.", "section_name": "Business Day", "print_page": null, "document_type": "blogpost", "byline": {"person": [{"firstname": "David", "role": "reported", "lastname": "GELLES", "rank": 1, "organization": ""}], "original": "By DAVID GELLES"}, "web_url": "http://dealbook.nytimes.com/2014/10/02/push-by-allergan-to-acquire-salix-loses-steam/", "lead_paragraph": null, "headline": {"main": "Push by Allergan to Acquire Salix Loses Steam ", "kicker": "DealBook"}, "_id": "542e0f0338f0d87d7534d08d", "word_count": "396", "multimedia": [{"height": 126, "url": "images/2014/09/24/business/dbpix-allergan/dbpix-allergan-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2014/09/24/business/dbpix-allergan/dbpix-allergan-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 400, "url": "images/2014/09/24/business/dbpix-allergan/dbpix-allergan-articleLarge.jpg", "legacy": {"xlarge": "images/2014/09/24/business/dbpix-allergan/dbpix-allergan-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "400"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2014/09/24/business/dbpix-allergan/dbpix-allergan-thumbStandard.jpg", "legacy": {"thumbnail": "images/2014/09/24/business/dbpix-allergan/dbpix-allergan-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2014-10-02T22:50:23Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "organizations", "value": "Allergan Inc", "rank": "1"}, {"name": "organizations", "value": "Pershing Square Capital Management", "rank": "2"}, {"name": "organizations", "value": "Salix Pharmaceuticals Ltd", "rank": "3"}, {"name": "organizations", "value": "Valeant Pharmaceuticals International Inc", "rank": "4"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": "1"}], "blog": [], "subsection_name": "Dealbook", "type_of_material": "Blog"}